SCHEMBL250080

SCHEMBL250080

C1CCC(N=C(NC2CCCCC2)NC2CCCCC2)CC1

nearest known ligand 0.91

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.91
EPHX1 P07099 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
KDM4E B2RXH2 1/20 0.46
EPHX2 P34913 1/20 0.46
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
MMP2 P08253 1/20 0.39
MMP8 P22894 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155365 0.91 SIGMAR1 (0.76) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL7623949 0.88 SIGMAR1 (0.71) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL7623945 0.88 SIGMAR1 (0.71) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL6154078 0.87 SIGMAR1 (0.70) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL18740827 0.86 SIGMAR1 (0.68) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL20981567 0.84 SIGMAR1 (0.65) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL20981566 0.84 SIGMAR1 (0.65) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL18230675 0.82 SIGMAR1 (0.63) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL20473401 0.82 SIGMAR1 (0.63) SIGMAR1EPHX1EPHX2
SCHEMBL18230676 0.82 SIGMAR1 (0.63) SIGMAR1EPHX1SMN1; SMN2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230064459-A1 LIGNIN BASED BIODEGRADABLE POLYMERS AND METHODS OF MAKING THE SAME The Florida State University Research Foundation, Inc. 2023-03-02 US claimed
EP-4087890-A1 LIGNIN BASED BIODEGRADABLE POLYMERS AND METHODS OF MAKING THE SAME The Florida State University Research Foundation, Incorporated (US) 2022-11-16 EP claimed
WO-2019157357-A1 PROCESSES FOR PREPARING CALIXARENES SI GROUP, INC. (US) 2019-08-15 WO claimed
US-20190248721-A1 PROCESSES FOR PREPARING CALIXARENES SI GROUP, INC. 2019-08-15 US claimed
US-9944593-B2 Process for the synthesis of fluoralkyl sulfonate salts SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2018-04-17 US claimed
WO-2012036392-A3 HUMAN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR FAB ANTIBODY AND A PHARMACEUTICAL COMPOSITION FOR TREATING TUMOURS COMPRISING THE SAME 주식회사 아이지세라피 (KR) 2012-05-10 WO claimed
EP-1930376-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2011-12-07 EP claimed
US-8013080-B2 Curable composition KANEKA CORPORATION (JP) 2011-09-06 US claimed
CN-101724509-A Method for continuously preparing fatty acid ester by using tower reactor NANJING UNIVERSITY OF TECHNOLOGY 2010-06-09 CN claimed
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine MALLE GERARD 2009-08-06 US claimed
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE L'OREAL S.A. 2009-06-04 US claimed
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin L'OREAL S.A. (FR) 2005-06-23 US claimed
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine L'OREAL 2005-06-16 US claimed
EP-1532963-A1 Composition for straightening the hair comprising at least one imine not being an hydroxide L'OREAL (FR) 2005-05-25 EP claimed
EP-1532960-A1 Hair styling composition containing a non-hydroxide imine L'OREAL (FR) 2005-05-25 EP claimed
US-20050042758-A1 Leak detection method using microencapsulated dye precursor HONEYWELL CORPORATION 2005-02-24 US claimed
EP-4692247-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2026-02-11 EP disclosed
US-20260022211-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2026-01-22 US disclosed
EP-0109838-A2 Light and heat-sensitive recording material FUJI PHOTO FILM CO., LTD. (JP) 1984-05-30 EP disclosed
US-4387150-A HYDROPHOBIC GUANIDINE COMPOUND AS DEVELOPER MITSUBISHI PAPER MILLS, LTD. (JP) 1983-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190248721-A1 PROCESSES FOR PREPARING CALIXARENES CALU, CALD1, CALR SIGMAR1 2456/4885EPHX1 1184/4885SMN1; SMN2 2954/4885
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE KRT18, INMT, INHA SIGMAR1 1743/4885EPHX1 3319/4885SMN1; SMN2 3027/4885
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine KRT18, KIT, PRDM7 SIGMAR1 3735/4885EPHX1 2311/4885SMN1; SMN2 3724/4885
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine KRT18, INHA, H1-5 SIGMAR1 2720/4885EPHX1 2359/4885SMN1; SMN2 3508/4885
US-20260022211-A1 CURABLE COMPOSITION H1-4, H1-0, H1-2 SIGMAR1 837/4885EPHX1 3313/4885SMN1; SMN2 990/4885
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin BHMT, KRT18, INMT SIGMAR1 1048/4885EPHX1 3675/4885SMN1; SMN2 3800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.